1051375-19-9|Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate|BLD Pharm

Startseite/ Inhibitors/Agonists/ Anti-infection/ HIV Integrase/Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate

Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate *Cold-chain transportation

CAS NO.： 1051375-19-9

Größe	Preis	Verkaufsrabatt	Rabatt	Lager-CN	Lager-US	Lager-IND	Lager-EU	Menge

How to Order +86-21-61629022 sales@bldpharm.com tech@bldpharm.com Catalog

The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

How to Order

PRODUKT INFORMATION

Produktdetails
Sicherheit

Produkt Name :	Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate
CAS Nr. :	1051375-19-9	Molekulargewicht :	441.36
MDL Nr. :	MFCD28405599	Feinheit/Spezifikation :
Molekularformel :	C₂₀H₁₈F₂N₃NaO₅	Lagerung :	Inert atmosphere,2-8°C
Siedepunkt :	No data available

GHS Pictogram :
Signal Word :	Warning	Precautionary Statements :	P261-P305+P351+P338
UN# :	-	Class :	-
Hazard Statements :	H302-H315-H319-H335	Packing Group :	-

Sodium (4R,12aS)-9-((2,4-difluorobenzyl)carbamoyl)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazin-7-olate *Cold-chain transportation

PRODUKT INFORMATION

ZUSAMMENHÄNGENDE PRODUKTE

HISTORISCHE AUFZEICHNUNGEN

Kontakt